Kevin Charles Gorman, Director: Neurocrine Biosciences NBIX Sell · Filed 25/01/29

Trade details

Type: Insider sale
Amount: $21,836,853.3
Shares · price: 146,105 sh · $149.46 a share
Held after: 514,596 sh
Stock: Neurocrine Biosciences NBIX
Person: Kevin Charles GormanDirector
Trade date: 25/01/27
Filed: 25/01/29
Days to filing: 2 days

Sold 22.1% of holdings

Share of holding sold: 22.1%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 24/12/28~25/02/26

Kevin Charles Gorman's recent trades

Kevin Charles GormanDirector
Sell10b5-1 planXencor
Sell10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/17
Traded 06/15
Kevin Charles GormanDirector
Planned sale10b5-1 planXencor
Planned sale10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/15
Traded 06/15
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$37.8M
245,088 sh
$37.8M
Filed 05/21
Traded 05/19
Kevin Charles GormanDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$38.5M
245,088 sh
$38.5M
Filed 05/19
Traded 05/19
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$13.4M
106,322 sh
$13.4M
Filed 25/08/11
Traded 25/08/07

Kevin Charles Gorman, Director — sold $21.8M of Neurocrine Biosciences NBIX · 22.1% of holdings · 10b5-1 plan | Whalegun